Drug Shortage Report for DEXTROSE INJECTION USP
| Report ID | 61848 |
| Drug Identification Number | 00037966 |
| Brand name | DEXTROSE INJECTION USP |
| Common or Proper name | Dextrose 20% Injection USP |
| Company Name | ICU MEDICAL CANADA INC |
| Market Status | MARKETED |
| Active Ingredient(s) | DEXTROSE |
| Strength(s) | 200MG |
| Dosage form(s) | SOLUTION |
| Route of administration | INTRAVENOUS |
| Packaging size | 20 g/100 ml |
| ATC code | B05BA |
| ATC description | I.V. SOLUTIONS |
| Reason for shortage | Requirements related to complying with good manufacturing practices. |
| Anticipated start date | 2018-09-19 |
| Actual start date | 2018-09-19 |
| Estimated end date | 2018-11-19 |
| Actual end date | 2019-10-31 |
| Shortage status | Resolved |
| Updated date | 2020-02-20 |
| Company comments | |
| Health Canada comments | |
| Contact Address | 2600 BOUL ALFRED-NOBEL, SUITE 100 SAINT LAURENT, QUEBEC CANADA H4S 0A9 |
| Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.